Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-24 @ 4:54 PM
Ignite Modification Date:
2025-12-25 @ 2:37 PM
NCT ID:
NCT05660850
Pre Assignment Details:
This study had 2 parts: Part A (main study): chronic refractory cough (CRC) with asthma with/without atopy \& unexplained chronic cough (UCC); and Part B (substudy): CRC with chronic obstructive pulmonary disease (COPD) with/without chronic bronchitis (CB). Participants were randomized in 1:1 ratio into 2 crossover sequences (14-day Treatment Periods 1 and 2) to receive GDC-6599 and placebo and were then followed up for safety during the 28-day Safety Follow-up Period.
Recruitment Details:
A total of 49 participants with chronic cough took part in the study at 22 investigative sites across Australia, Canada, the United States, and the United Kingdom from 22 March 2023 to 20 October 2024. The study was terminated due to the sponsor's decision to discontinue the clinical development of GDC-6599.
Study:
NCT05660850
Study Brief:
Results Section:
NCT05660850